Reich, K., Papp, K., Blauvelt, A., Langley, R., Armstrong, A., Warren, R., Gordon, K., Merola, J., Madden, C., Wang, M., Vanvoorden, V. and Lebwohl, M. (2020) “Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study”, SKIN The Journal of Cutaneous Medicine, 4(6), p. s82. doi: 10.25251/skin.4.supp.82.